One of NeurotechEU’s collective ambitions is to accelerate responsible neuro-innovation that benefits people and society across Europe. Within this framework, NeurotechEU aims to strengthen collaboration inside and outside the alliance and to devise a technology-transfer strategy that turns neurotechnological advances into high-impact applications for Europe’s society and economy. As part of this objective, the Boğaziçi Üniversitesi (BOUN, Turkey), a member of The European University of Brain and Technology–NeurotechEU, hosted the NeurotechEU 2025 Neuroinnovation Summit. With the topic “A Strategic Roadmap for NeurotechEU: Evidence-Based Knowledge and Technology Co-Production”, from 25-28 September 2025, representatives from Universidad Miguel Hernández de Elche (UMH) and other universities in the alliance, as well as stakeholders, have met to discuss how to translate the findings of WorkPackage 4 team, ‘Common Policies and Strategy Development’, into a strategic roadmap that will guide research agendas, joint educational programs, and policy dialogues in the years to come.

UMH has been represented by the leader of NeurotechEU at UMH and Director of the Institute for Neuroscience UMH-CSIC, Juana Gallar, who was accompanied by the Deputy Vice-Rector for Research Management, José María Azorín; the director of the Centre for Translational Research in Physiotherapy, Maria del Carmen Lillo; and the UMH representative on the NeurotechEU Student Council, Jorge Maldonado. The UMH delegation was completed by Pablo Belmonte Brissoire, Chief Executive Officer of the UMH spin-off company Newmanbrain.

During this two-and-a-half-day event, attendees worked on translating what has been found into actions according to different targets. The NeurotechEU Summit was organized into keynote sessions, panel discussions, lightning talks, and parallel working sessions. Gallar moderated two sessions and gave the lightning talk entitled: “From Basic Science to the End-User: An FDA-Approved Drug & a Diagnostic Device”. Azorín presented the talk “Lessons Learned from Clinical Tests of BCI Systems and Exoskeletons”. Lillo, co-author of the document central to the Summit, participated in the “Understanding Societal Challenges: Applications and Social Initiatives” discussion panel. Belmonte presented the evolution of his company as an example in the “Translation into Industry: Challenges, Opportunities, and Success Stories” Nanosymposium.

The Neuroinnovation Summit is one of the activities that NeurotechEU organizes yearly as a European Alliance committed to promoting the education and training of future professionals and researchers in the field of neurotechnology in an innovative and up-to-date way. The NeurotechEU Alliance currently includes eight European universities: Radboud University Nijmegen (Netherlands), UMH, Karolinska Institutet (Sweden), University of Bonn (Germany), Boğaziçi University (Turkey), Iuliu Hațieganu University of Medicine and Pharmacy (Romania), University of Lille (France), and Reykjavik University (Iceland).